Amy Yenyo, JD, MPHAssociate Director, Policy, Market Access and Public Affairs at Novo Nordisk
Amy brings over twenty years of experience working in health law, public policy, and government relations. She joins Novo Nordisk as an Associate Director of Policy after serving as Principal of Community Services Consulting and Senior Policy Counsel at a national, non-profit health care association. In these positions, Amy provided expert analysis and strategic counsel on drug pricing policy, with an emphasis on Medicaid and the 340B Drug Pricing Program
Amy holds a Juris Doctor from the University of Houston Law Center and a Master of Public Health from the University of Texas. She earned a Bachelor of Science degree from the College of William and Mary in Virginia. Amy has a long history of community service with various boards supporting individuals with disabilities.
Policy Reform for Medicaid and Government Pricing Stakeholders, 11:25amView Session